期刊文献+

钱仁义治疗重症肌无力临证经验

Qian Renyi’s experience in treating myasthenia gravis
下载PDF
导出
摘要 重症肌无力是一种获得性自身免疫性疾病,是目前公认的难治性疾病之一,目前尚无根治的方法。钱仁义教授从脾肾虚损论治重症肌无力,认为该病关键病机为脾肾虚损,提出以益气补肾、扶阳升清为主要治疗准则。文章从病因病机、治法方药方面对钱老师治疗重症肌无力的经验进行总结,以期为临床提供借鉴。 Myasthenia Gravis is an acquired autoimmune disease.It is one of the most recognized intractable diseases in the world.There is no cure.Professor Qian renyi treat myasthenia gravis from spleen and kidney deficiency,it is believed that the pathogenesis of this disease is deficiency ofspleen-qi,deficiency of kidney essence.Propositting the main treatment criterion of yiqi supplemental kidney fuyang shengqing.This paper summarizes Professor Qian s experience on myasthenia gravis from aetiology pathogenesis,prescription.
作者 马志鹏 张金燕 钱仁义 MA Zhipeng;ZHANG Jinyan;Qian Renyi(Henan University of Traditional Chinese Medicine,Zhengzhou 450000,China;The First Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou 450000,China)
出处 《中国民族民间医药》 2019年第18期73-74,共2页 Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词 重症肌无力 钱仁义 临证经验 Myasthenia Grauis Professor Qian Renyi Clinical Experience
  • 相关文献

参考文献4

二级参考文献25

  • 1薛志强,王如文,蒋耀光,马铮,赵云平,谭群友.成人重症肌无力胸腺切除术后远期生活质量评价[J].第三军医大学学报,2004,26(9):817-819. 被引量:9
  • 2彭丹涛,许贤豪,佘子瑜.新斯的明试验改良结果判定法研究[J].中国神经免疫学和神经病学杂志,2007,14(1):1-3. 被引量:26
  • 3[1]Lefvert AK.Human and experimental myasthenia gravis[M].In:Wiley,ed.Autoimmunity:physiology and diseases,1994.267-272.
  • 4[2]Yi Q,Lefvert AK.Current and future therapies for myasthenia gravis[J].Drugs Aging,1997,11(2):132.
  • 5[3]Adams DO,Hamilton TA.Molecular trmsductional mechanisms by which IFN-γand other signals regulate macrophage devdepment.[J].Immunol Rev,1987,97:5.
  • 6[4]Collart MA,Belin J,Nassalli D,et al.Camma-interferon enhances macrophage transcription of the tumor necrosis factor/cachetin,interleukin-1,and urokinase genes,which are controled by shot-lived repressors[J].J Exp Med,1986,164:2113.
  • 7[5]Ahlberg RE,Pirskarlen R,Lefvert AK,et al.Detective Tlymphecyte function in nonthymectomized patients with myasthenia gravis[J].Clin Immunopathol,1991,60:93.
  • 8Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and tuture[J]. J Clin Invest, 2006, 116(11): 2843-2854.
  • 9Kerry E, Elsais A, Argov Z, et al. NE. EFNS/ENS Guidelines for the treatment of ocular myasthenia [ J ]. Eur J Neurol, 2014, 21(5) : 687-693.
  • 10Luehanok U, Kaminski HJ. Ocular myasthenia: diagnostic and treatment recommendations and the evidence basel[ J ]. Curr Opin Neurol, 2008, 21 ( 1 ) : 8-15.

共引文献295

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部